Literature DB >> 11255262

Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation.

H Duan1, L M Tsvetkov, Y Liu, Y Song, M Swaroop, R Wen, H F Kung, H Zhang, Y Sun.   

Abstract

The sensitive-to-apoptosis gene (SAG) was initially identified as a redox-inducible, apoptosis-protective protein and subsequently found to be the second family member of regulator of cullins (ROC)/RING box protein (Rbx)/Hrt, which acts as a component of E3 ubiquitin ligase. We report here that SAG promoted cell growth under serum starvation. Microinjection of SAG mRNA into quiescent NIH/3T3 cells induced S-phase entry as determined by [(3)H]-thymidine incorporation. Likewise, overexpression of SAG by either adenovirus infection of immortalized human epidermal keratinocytes (Rhek-1) or DNA transfection of SY5Y human neuroblastoma cells induced cell proliferation under serum starvation. Because cyclin-dependent kinase inhibitors (CKIs), including p21, p27, and p57, are degraded through the ubiquitin pathway, we tested whether SAG-induced cell growth is associated with CKI degradation. Although there was no significant difference in the levels of p21 and p57 between the vector controls and SAG-overexpressing cells, serum starvation induced 10- to 18-fold accumulation of p27 in control Rhek-1 cells. Accumulation of p27 was remarkably inhibited (only 2 to 5-fold) in SAG-infected cells. Inhibition of p27 accumulation was also observed in stably SAG-overexpressing SY5Y cells. Significantly, SAG-associated inhibition of p27 accumulation was largely abolished by the treatment with a proteasome inhibitor. In vivo binding of SAG and Skp2, an F-box protein that promotes p27 ubiquitination, was detected, and the binding was enhanced in SAG-overexpressing cells grown under serum starvation. Thus, SAG-induced growth with serum withdrawal appears to be associated with SAG-mediated p27 degradation. Mol. Carcinog. 30:37-46, 2001. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255262     DOI: 10.1002/1098-2744(200101)30:1<37::aid-mc1011>3.0.co;2-7

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  19 in total

1.  CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity.

Authors:  Hongbin He; Mingjia Tan; Deepika Pamarthy; Guixia Wang; Khalil Ahmed; Yi Sun
Journal:  Mol Cell Biochem       Date:  2006-07-28       Impact factor: 3.396

2.  Fine-mapping quantitative trait loci affecting murine external ear tissue regeneration in the LG/J by SM/J advanced intercross line.

Authors:  J M Cheverud; H A Lawson; K Bouckaert; A V Kossenkov; L C Showe; L Cort; E P Blankenhorn; K Bedelbaeva; D Gourevitch; Y Zhang; E Heber-Katz
Journal:  Heredity (Edinb)       Date:  2014-02-26       Impact factor: 3.821

3.  SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.

Authors:  Mingjia Tan; Jayme R Gallegos; Qingyang Gu; Yuanhui Huang; Jun Li; Yetao Jin; Hua Lu; Yi Sun
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

4.  Effects of sensitive to apoptosis gene protein on cell proliferation, neuroblast differentiation, and oxidative stress in the mouse dentate gyrus.

Authors:  Dae Young Yoo; Bich Na Shin; In Hye Kim; Dae Won Kim; Ki-Yeon Yoo; Woosuk Kim; Choong Hyun Lee; Jung Hoon Choi; Yeo Sung Yoon; Soo Young Choi; Moo-Ho Won; In Koo Hwang
Journal:  Neurochem Res       Date:  2011-10-30       Impact factor: 3.996

Review 5.  E3 ubiquitin ligases as cancer targets and biomarkers.

Authors:  Yi Sun
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

6.  Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.

Authors:  Dongping Wei; Yi Sun
Journal:  Genes Cancer       Date:  2010-07

7.  Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer.

Authors:  Sevgi A Ozden; Hazan Ozyurt; Zerrin Ozgen; Olca Kilinc; Mustafa Oncel; Aylin E Gul; Nimet Karadayi; Nedime Serakinci; Beki Kan; Oya Orun
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

Review 8.  SCF E3 ubiquitin ligases as anticancer targets.

Authors:  L Jia; Y Sun
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

9.  Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.

Authors:  Hua Li; Mingjia Tan; Lijun Jia; Dongping Wei; Yongchao Zhao; Guoan Chen; Jie Xu; Lili Zhao; Dafydd Thomas; David G Beer; Yi Sun
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

Review 10.  Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.

Authors:  Yi Sun; Hua Li
Journal:  Protein Cell       Date:  2012-11-08       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.